Clinical Trial Update: Sirolimus for Leigh Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating sirolimus for Leigh syndrome, with enrollment currently listed as enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leigh Syndrome

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Matthew Demczko | Conditions: Leigh Syndrome | Phase 2 | Status: ENROLLING_BY_INVITATION